Powered by

Milestone Pharmaceuticals to Host Mid-Year Update Conference Call

Aug 06, 2019 - PR Newswire

PR Newswire

 Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced that it will host a mid-year update conference call on Tuesday, August 13, 2019 at 8:00 a.m. Eastern Time.

To access the live call by phone, dial (800) 529-3311 (domestic) or (470) 495-9164 (international) and enter the passcode 9498516. A live webcast of ...